Is Ventas Stock Outperforming the S&P 500?

Core Viewpoint - Ventas, Inc. is a leading U.S. real estate investment trust (REIT) focused on healthcare and senior living assets, with a market cap of $37.6 billion, and is well-positioned to benefit from the aging population trend [1][2]. Company Overview - Ventas operates a diversified portfolio that includes senior housing communities, medical office buildings, life science facilities, and hospitals, targeting the growing aging population [1]. - The company is classified as a large-cap stock, valued over $10 billion, and is perceived as having stable cash flows and moderate growth prospects [2]. Stock Performance - Ventas shares have decreased by 5.1% from their 52-week high of $81.89, but have increased by 12.3% over the past three months, outperforming the S&P 500 Index's 5.4% gain during the same period [3]. - Year-to-date, Ventas shares have risen by 32%, surpassing the S&P 500's 17.1% increase, and have gained nearly 27.1% over the past 52 weeks compared to the S&P 500's 14.1% rise [4]. Financial Performance - In Q3, Ventas reported a 20.4% increase in total revenues to $1.5 billion, exceeding consensus estimates by 3.9%, driven by an 8% year-over-year rise in same-store cash operating revenues [5]. - The company has actively expanded its portfolio, deploying $2.2 billion towards senior housing acquisitions in the first nine months of 2025 [5]. Competitive Landscape - Ventas's competitor, Welltower Inc. (WELL), has shown stronger stock performance, with a year-to-date increase of 51.6% and a 52-week rise of 47.8% [6].